Home » Speakers

Speakers

Cell and Gene Therapy World Congress 2024 Europe

"Driving Innovation, Addressing Significant Unmet Medical Needs, and Ultimately Improving Patient Outcomes"

3rd - 4th October 2024, Hilton London Kensington, LONDON, UK

KEY INDUSTRY EXPERT SPEAKERS

Eric Halioua

President & Chief Executive Officer

PDC*line Pharma

JEFF LITER

CEO

OX2 Therapeutics

ALEX BLYTH

Founder & CEO

Lift Biosciences

ALEXANDER NATZ

Secretary General

EUCOPE

MOHAMED OUBIHI PH.D.

Founder and CEO

YAKUMED LIMITED

DR LILIAN HOOK

Director Cell, Apheresis & Gene Therapies

NHS Blood and Transplant

DR. RON JORTNER

Founder/CEO

Aspire Biosciences

PROF HARRIS MAKATSORIS

Professor of Manufacturing Systems, Department of Engineering

King’s College London

EUGEAN JIWANMALL

Senior Research Analyst

Independence Blue Cross

MARCO TRAUB

CEO

The Trans European Stem Cell Therapy Society

ADAM GLEN

Co-founder

Unicorn Bio

Dr Theres Oakes

Head of Product Characterisation

Achilles Therapeutics

Daniel Gibson

Director of Cell and Gene

Anthony Nolan

Amir Hefni

Global Head for Cell & Gene Therapy

Novartis

Stefanos Theoharis

Senior Executive

Independent Expert

Dr. Anand Srivastava

Chairman and Co-founder

Global Institute of Stem Cell Therapy and Research

MANAL MORSY

Executive Vice President, Head of Global Regulatory Affairs

Athersys, Inc.

THOMAS MUELLER

Head of Directorate General “Drugs, Medical Devices, Biotechnology”

Federal Ministry of Health, Germany

REAGAN JARVIS

CEO and Co-founder

Anocca

BEN DOAK

Head of Innovative Treatments

NHS England

CECILIA GÖTHERSTRÖM

Research Group leader, Associate Professor in Stem Cell Science

Karolinska Institutet

ALBERTO MALERBA

Lecturer in Gene Therapy

Royal Holloway, University of London

STUART M CURBISHLEY

Chief Manufacturing and Chief Development Officer

adthera bio

JULIA DJONOVA

Head, Advanced Therapy Medicinal Products

Swissmedic

DOUG DANISON

Head of Commercial, Cell and Gene Therapy Unit

Bayer

Dr Chris Williams

SVP Corporate Development

Autolus Ltd

Dr. Thomas Schochat

Clinical Assessor, Division Advanced Therapy Products

Swissmedic

MATTHIAS BOZZA

Director

Vector BioPharma

Scroll to Top